Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Non Operating Interest Expenses (2017)

Updated

Crinetics Pharmaceuticals' Non Operating Interest Expenses came in at $1,000 for Q4 2017, down 50.0% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Non Operating Interest Expenses (2017) Analysis & Trends

For FY2017, Crinetics Pharmaceuticals' Non Operating Interest Expenses was $8,000, down 27.3% from FY2016.

  • Going back by year, Non Operating Interest Expenses was $11,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1,000.00
Sep 30, 2017 2,000.00
Jun 30, 2017 3,000.00
API Access

Crinetics Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CRNX&period=max&api_key=YOUR_API_KEY